Skip to main content

Table 4 Total Public Expenditure on OMPs in 2013 and 2014 compared to GDP, Total Pharmaceutical and Healthcare Budget

From: The European challenges of funding orphan medicinal products

  Austriac Belgium Bulgaria Czech Republic Hungary Poland Slovenia
2013
 Total public expenditures on OMPs (thousand €) 98,600a 245,000a 8266a 42,340a 32,262a 50,649a 16,893a
 Total GDP (thousand €) 322,539,200b 391,712,000b 42,011,500b 157,741,600b 101,483,300b 394,721,100b 35,917,100b
 Total public expenditures on OMPs in proportion of GDP (%) 0.03% 0.06% 0.02% 0.03% 0.03% 0.01% 0.05%
 % of total pharmaceutical expenditures 3.74% e 6.18% f 3.07% g 2.00% h 3.42% i 1.95% j 4.65% k
 % of total healthcare expenditures NA 0.91% f NA 0.4% h 0.53% i 0.34% j 0.74% k
 Total pharmaceutical expenditures (thousand €) (calculated) 2,636,364 3,964,401 269,248 2,117,013 943,332 2,597,381 363,297
 Total healthcare expenditures (thousand €) (calculated) NA 26,923,077 NA 10,585,065 6,087,161 14,896,746 2,282,879
2014        
 Total public expenditures on OMPs (thousand €) (Growth compared to 2013, %) 109,800 (+ 11.4%)a 280,000 (+ 14.3%)a 12,228 (+ 47.9%)a 50,835 (+ 20.1%)a 40,498 (+ 25.5%)a 83,341 (+ 64.5%)a 19,854 (+ 17.5%)a
 Total GDP (thousand €) 330,417,600b 400,805,000b 42,762,200b 166,964,100b 104,953,300b 410,989,700b 37,332,400b
 Total public expenditures on OMPs in proportion of GDP (%) 0.03% 0.07% 0.03% 0.03% 0.04% 0.02% 0.05%
 % of total pharmaceutical expenditures 3.94%e 6.84% f 4.15% g 2.50% h 4.25% i 3.2% j 5.47% k
 % of total healthcare expenditures NA 1.01% f NA 0.60% h 0.66% i 0.54% j 0.84% k
 Total pharmaceutical expenditures (thousand €) (calculated) 2,786,802 4,093,567 294,654 2,033,406 952,883 2,604,432 362,956
 Total healthcare expenditures (thousand €) (calculated) NA 27,722,772 NA 8,472,525 6,135,990 15,433,670 2,363,538
Total public expenditures on OMPs in proportion of GDP (%) in 2013 0.03% 0.06% 0.02% 0.03% 0.03% 0.01% 0.05%
Total public expenditures on OMPs in proportion of GDP (%) in 2014 0.03% 0.07% 0.03% 0.03% 0.04% 0.02% 0.05%
Average 0.03% 0.07% 0.02% 0.03% 0.04% 0.02% 0.05%
Total public expenditure on OMPs as a proportion of total public pharmaceutical expenditures in 2013 3.74% 6.18% 3.07% 2.00% 3.42% 1.95% 4.65%
Total public expenditure on OMPs as a proportion of total public pharmaceutical expenditures in 2014 3.94% 6.84% 4.15% 2.50%d 4.25% 3.20% 5.47%
Average 3.84% 6.51% 3.61% 2.25% 3.84% 2.58% 5.06%
Total public expenditure on OMPs as a proportion of total public healthcare expenditures in 2013 NA 0.91% NA 0.40% 0.53% 0.34% 0.74%
Total public expenditure on OMPs as a proportion of total public healthcare expenditures in 2014 NA 1.01% NA 0.60%d 0.66% 0.54% 0.84%
Average NA 0.96% NA 0.50% 0.60% 0.44% 0.79%
  1. Sources: a Data was given from Table 1
  2. bhttp://ec.europa.eu/eurostat/tgm/refreshTableAction.do?tab=table&plugin=1&pcode=tec00001&language=en
  3. cOrphan drug expenditure in hospitals not included
  4. dData was not available at time of data request. this number assumes same total expenditure on public healthcare as in year 2013
  5. eFederation of Austrian Social Insurance Institutions (Hauptverband der österreichischen Sozialversicherungsträger)
  6. fNational Institute for Health and Disability Insurance of Belgium (Institut National d'Assurance Maladie-Invalidité / Rijksinstituut voor ziekte-en invaliditeitsverzekering, INAMI / RIZIV)
  7. gNational Health Insurance Fund of Bulgaria, National Council on Prices and Reimbursement of Medicinal Products
  8. hState Institute for Drug Control (Státní ústav pro kontrolu léčiv, SUKL)
  9. iNational Health Insurance Fund Administration of Hungary (Országos Egészségbiztosítási Pénztár, OEP)
  10. jNational Health Fund (Narodowy Fundusz Zdrowia), Ministry of Health (Ministerstwo Zdrowia)
  11. kHealth Insurance Institute of Slovenia (Zavod za zdravstveno zavarovanje Slovenije, ZZZS)